Considering the pivotal value of PD-1/PD-L1 axis in tumor immunity (Sun et al., 2018), we wondered how IR combined PD-L1−/− triggered the immune response to achieve an antitumor efficacy and thus profiled the composition of tumor-infiltrating T lymphocytes after IR on the primary tumor. Here, PDCD1 is linked to neoplasm.